<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11067">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02962882</url>
  </required_header>
  <id_info>
    <org_study_id>PUP16_01</org_study_id>
    <nct_id>NCT02962882</nct_id>
  </id_info>
  <brief_title>Pressure Injury Prevention in the ICU With Multi-Layer Foam Dressings</brief_title>
  <acronym>PUP16_01</acronym>
  <official_title>A Multi-Centre, Open, Non-controlled, Clinical Investigation to Evaluate the User Friendliness and Wear Time of Multi-layer Foam Dressings With Safetac® for Pressure Injury Prevention in the Intensive Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Molnlycke Health Care AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Molnlycke Health Care AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Multi-Centre, Open, Non-controlled, Clinical Investigation to Evaluate the User
      Friendliness and Wear Time of Multi-layer Foam Dressings With Safetac® for Pressure Injury
      Prevention in the Intensive Care Unit
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>User Friendliness of both sacrum and heel (left &amp; right) dressings: comfort, conformability, acceptability, the handling at application and ease of inspection of the dressings as well as reapplication</measure>
    <time_frame>4-6 days</time_frame>
    <description>User friendliness judged by site staff, with the following variables; Ability to stay in place Facilitation of inspection of skin Ease of reapplication following skin inspection Conformability to contours of the body Overall impression of dressing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wear Time in ICU</measure>
    <time_frame>4-6 days</time_frame>
    <description>Maximum length of wear time/stay on ability of dressings in ICU.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence of AE/ADE/SAE/SADE/DD</measure>
    <time_frame>1-6 days</time_frame>
    <description>AE=Adverse Event, SAE= Serious Adverse Event, SADE= Serious Adverse Device Event, DD= Device Defficiency</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Pressure Incidence Prevention</condition>
  <arm_group>
    <arm_group_label>Sacrum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mepilex Border Sacrum (Safetac)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mepilex Border Heel ( Safetac)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mepilex Border</intervention_name>
    <description>Multi-layer Foam Dressings</description>
    <arm_group_label>Sacrum</arm_group_label>
    <arm_group_label>Heel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is at risk for developing a pressure injury to the heels and/or sacrum

          -  Aged ≥ 18 years

          -  Patient or his/her legal representative is able to understand and voluntarily sign
             the informed consent

          -  Estimated treatment period in ICU for patient at least 4-6 days

        Exclusion Criteria:

          -  Patient has a pressure injury or blistering on sacrum and/or heels

          -  Patient with known or suspected sensitivity to any of the components of the products
             being evaluated

          -  Patient included in other clinical investigations at present or within the last 30
             days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kelli Potter, RN, CWON</last_name>
    <email>kelli.potter@anmedhealth.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tampa General</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anmed Health</name>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <zip>29621</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy Betsill, MS, RN, CNS</last_name>
      <email>Kathy.Betsill@Anmedhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Roper Hospital</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>November 9, 2016</lastchanged_date>
  <firstreceived_date>August 23, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
